Kim Hørslev-Petersen

Professor

University of Southern Denmark

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kim Hørslev-Petersen is a Professor at the University of Southern Denmark. His research focuses on rheumatoid arthritis, particularly in areas such as disease biomarkers, treatment strategies, and patient-reported outcomes. Recent articles by Professor Hørslev-Petersen examine the prediction of disease progression and the impact of socioeconomic factors on treatment efficacy in rheumatoid arthritis. He is dedicated to advancing the understanding of inflammatory arthritis and improving patient care.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Stinne Greisen

Aarhus University

DENMARK

View details

Merete Lund Hetland

Professor

University of Copenhagen

DENMARK

View details

Kristian Stengaard-Pedersen

Aarhus University

DENMARK

View details

Bent Deleuran

Aarhus University

DENMARK

View details

Carsten Jensen

Ass. Prof

Odense University Hospital

DENMARK

View details

Mikkel Østergaard

Professor

Rigshospitalet

DENMARK

View details

Hanne Merete Lindegaard

University of Southern Denmark

DENMARK

View details

Dzenan Masic

Aarhus University

DENMARK

View details

Malene Hvid

Aarhus University

DENMARK

View details

Aida Hansen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kim Hørslev-Petersen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis

Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission

Plasma haem oxygenase-1 may represent a first-in-class biomarker of oxidative stress in rheumatoid arthritis

Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.

Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate

Foot and Ankle Problems in Patients With Rheumatoid Arthritis in 2019: Still an Important Issue

Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study

Does socioeconomic status make a difference? A register-based study on the extent to which cardiovascular screening in patients with inflammatory arthritis leads to recommended follow-up in general practice

Impact of season on the association between vitamin D levels at diagnosis and one-year remission in early Rheumatoid Arthritis

Flares in rheumatoid arthritis: do patient-reported swollen and tender joints match clinical and ultrasonography findings?

Collaborators (10)

Stinne Greisen

Merete Lund Hetland

Kristian Stengaard-Pedersen

Bent Deleuran

Carsten Jensen

Mikkel Østergaard

Hanne Merete Lindegaard

Dzenan Masic

Malene Hvid

Aida Hansen

Make your next move.